These Six Stocks Are Under $5 – And At Least 50% Below Their Target Price
Today’s article highlights six low-priced stocks that are in uptrends – and which analysts believe could double in value. Specifically, each of these six stocks…
Biopharmaceutical Stocks
Stocks To Cash In On The $35 Billion NASH Dash
Non-alcoholic steatohepatitis (NASH) is expected to become the leading cause of all liver transplants by 2020 – and there is currently no approved treatment for…
Putting Factors To Work: 3 Cheap Stocks Exhibiting Value, Growth & Momentum
The author of today’s article refers to factors as the “historical return drivers in portfolios” and advises that “understanding how factors work can help you…